Official reprint from UpToDate®

www.uptodate.com © 2024 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

© 2024 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Selected adverse effects of antipsychotic medications for schizophrenia [1,2]

Weight Glucose Tardive Pro

Hyperlipidemia Akathisia Parkinsonism Dystonia
gain abnormalities dyskinesia elev

Second-generation agents

Aripiprazole + + + ++ + + +

Asenapine ++ ++ ++ ++ + ++ ++

Brexpiprazole ¶ + + ++ ++ + + +

Cariprazine ¶ ++ + + ++ + + +

Clozapine Δ +++ +++ +++ + + + +

Iloperidone ++ ++ + + + + +

Lumateperone ¶ + + + + + + +

Lurasidone + ++ ++ ++ ++ ++ ++

Olanzapine +++ +++ +++ ++ ++ + +

Paliperidone ++ + ++ ++ ++ ++ ++ +

Pimavanserin – + + + + + +

Quetiapine ++ ++ +++ + + + +

Risperidone ++ ++ + ++ ++ ++ ++ +

Ziprasidone + + + ++ + + +

First-generation agents

Chlorpromazine ++ ++ + ++ ++ ++ +++

Fluphenazine ++ + + +++ +++ +++ +++ +

Haloperidol ++ + + +++ +++ +++ +++ +

Loxapine + + + ++ ++ ++ ++

Molindone + + + ++ ++ ++ ++

Perphenazine ++ + + ++ ++ ++ ++

Pimozide + + + +++ +++ ++ +++ +

Thioridazine § ++ + + + + + +

Thiothixene + + + +++ +++ +++ +++ +

Trifluoperazine ++ + + ++ ++ ++ ++

Adverse effect rankings, with the exception of the QTc classifications, are consistent with American Psychiatric Association practice guidelines for
the treatment of schizophrenia. [1] The QTc classifications are determined by Lexicomp according to US Food & Drug Administration guidance. [2,3]
Other sources may use different classification systems resulting in some agents being classified differently.

IV: intravenous.

* Clinically significant QTc prolongation was not detected in preliminary studies or reported in the manufacturer's labeling.

¶ Based upon limited experience.

Δ Clozapine also causes granulocytopenia or agranulocytosis in approximately 1% of patients requiring regular blood cell count monitoring.
Clozapine has been associated with excess risk of myocarditis and venous thromboembolic events including fatal pulmonary embolism. These
issues are addressed in the UpToDate topic review of guidelines for prescribing clozapine section on adverse effects.

◊ Although the available evidence concerning the average QTc prolonging effect of pimozide is consistent with a classification of moderate
significance (ie, ++), label warnings have characterized the QTc effect and cardiovascular risks as severe and sudden deaths in patients on
pimozide have been reported.

§ Thioridazine is also associated with dose-dependent retinitis pigmentosa. Refer to UpToDate text.

References:
1. Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. American Psychiatric
Association 2020. Available at: https://www.psychiatry.org/psychiatrists/practice/clinical-practice-guidelines (Accessed on March 24, 2020).
2. Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.
 3. Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythic Potential for Non-Antiarrhythmic Drugs – Questions and Answers; Guidance for Industry US Food and
Drug Administration, June 2017 (revision 2). Available at: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073161.pdf.

Graphic 82533 Version 42.0